Researchers at the University of Copenhagen have identified important mechanisms underlying how a special type of malignant brain tumor arises in children. Not only do these discoveries give researchers important information ...
Feb 28, 2017
0
2
UCLA researchers have discovered that combining a vaccine developed at UCLA with other experimental therapies and FDA-approved treatments shows promise for reducing the size of advanced brain tumors. The immunotherapy, which ...
Jan 25, 2017
0
2
Malignant melanoma is the fastest-growing type of cancer and the most fatal skin disease. Sandra Iden and her team at the Cluster of Excellence on Aging Research (CECAD) at the University of Cologne investigated the influence ...
Jan 24, 2017
0
1
The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers. A team of researchers from CNRS, the French National Institute of Health and Medical Research (INSERM), ...
Jan 3, 2017
0
2
What makes cancer so deadly is its ability to move . The better that doctors can keep tumors contained and protect unaffected organs in the body, the less lethal a cancer will be.
Dec 20, 2016
0
1
Tumor necrosis factor inhibitors, a group of biologic drugs used to treat children with juvenile idiopathic arthritis, are not associated with a significantly increased risk of cancer, according to new research findings presented ...
Nov 13, 2016
0
0
A research team at the Krembil Research Institute has discovered that a signaling pathway which controls blood vessel development in the brain has the ability to stop brain tumor formation in animal models of medulloblastoma, ...
Nov 8, 2016
0
3
While the role of estrogen signaling in tumor development is well understood in breast and ovarian cancer, its role in anti-tumor immunity has not been extensively studied. However, new research from The Wistar Institute ...
Oct 17, 2016
0
2
Privately insured people with two types of cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two new studies.
Sep 23, 2016
0
2
Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.
Aug 26, 2016
0
0
